PortfoliosLab logoPortfoliosLab logo
CTAS vs. CI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CTAS vs. CI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cintas Corporation (CTAS) and The Cigna Group (CI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CTAS achieves a 9.35% return, which is significantly higher than CI's 2.54% return. Over the past 10 years, CTAS has outperformed CI with an annualized return of 23.95%, while CI has yielded a comparatively lower 9.54% annualized return.


CTAS

1D
-1.04%
1M
12.82%
6M
7.46%
YTD
9.35%
1Y
-6.74%
3Y*
18.61%
5Y*
16.82%
10Y*
23.95%
ALL TIME*
16.34%

CI

1D
-2.99%
1M
-3.03%
6M
2.96%
YTD
2.54%
1Y
8.77%
3Y*
-0.02%
5Y*
5.92%
10Y*
9.54%
ALL TIME*
10.94%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$460.57M$474.33M$477.27M
$538.80M$519.54M$423.07M

CTAS vs. CI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CTAS
Cintas Corporation
9.35%3.78%22.24%34.82%2.97%26.51%32.74%61.73%9.04%36.32%
CI
The Cigna Group
2.54%1.72%-6.27%-7.97%46.68%12.29%1.83%7.70%-6.46%52.29%

Correlation

The correlation between CTAS and CI is 0.17, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.17

Correlation (3Y)
Balances recent behavior with more history.

0.18

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.26

Correlation (10Y)
Provides a long-term view across more market conditions.

0.30

Correlation (All Time)
Calculated using the full available price history since Mar 26, 1990

0.28

The correlation between CTAS and CI shifts across timeframes, from 0.17 (1 year) to 0.30 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CTAS:

$81.89B

CI:

$73.82B

EPS

CTAS:

$4.92

CI:

$24.16

PE Ratio

CTAS:

41.61

CI:

11.55

PEG Ratio

CTAS:

3.04

CI:

0.67

PS Ratio

CTAS:

7.39

CI:

0.26

PB Ratio

CTAS:

16.10

CI:

1.73

Total Revenue (TTM)

CTAS:

$11.26B

CI:

$282.38B

Gross Profit (TTM)

CTAS:

$5.71B

CI:

$17.96B

EBITDA (TTM)

CTAS:

$2.99B

CI:

$9.16B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CTAS vs. CI — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CTAS
CTAS Risk / Return Rank: 3131
Overall Rank
CTAS Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
CTAS Sortino Ratio Rank: 2626
Sortino Ratio Rank
CTAS Omega Ratio Rank: 2727
Omega Ratio Rank
CTAS Calmar Ratio Rank: 3535
Calmar Ratio Rank
CTAS Martin Ratio Rank: 3737
Martin Ratio Rank

CI
CI Risk / Return Rank: 5151
Overall Rank
CI Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
CI Sortino Ratio Rank: 4646
Sortino Ratio Rank
CI Omega Ratio Rank: 4747
Omega Ratio Rank
CI Calmar Ratio Rank: 5353
Calmar Ratio Rank
CI Martin Ratio Rank: 5454
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CTAS vs. CI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cintas Corporation (CTAS) and The Cigna Group (CI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CTASCIDifference
Sharpe ratioReturn per unit of total volatility

-0.52

Sortino ratioReturn per unit of downside risk

-0.77

Omega ratioGain probability vs. loss probability

0.97

1.07

-0.10

Calmar ratioReturn relative to maximum drawdown

-0.26

0.31

-0.58

Martin ratioReturn relative to average drawdown

-0.43

0.74

-1.17

CTAS vs. CI - Sharpe Ratio Comparison

The current CTAS Sharpe Ratio is -0.31, which is lower than the CI Sharpe Ratio of 0.21. The chart below compares the historical Sharpe Ratios of CTAS and CI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CTAS vs. CI - Drawdown Comparison

The maximum CTAS drawdown since its inception was -65.32%, smaller than the maximum CI drawdown of -84.34%. Use the drawdown chart below to compare losses from any high point for CTAS and CI.


Loading charts...

Drawdown Indicators


CTASCIDifference

Max Drawdown

Largest peak-to-trough decline

-65.32%

-84.34%

+19.02%

Max Drawdown (1Y)

Largest decline over 1 year

-27.23%

-21.41%

-5.82%

Max Drawdown (3Y)

Largest decline over 3 years

-27.68%

-32.10%

+4.42%

Max Drawdown (5Y)

Largest decline over 5 years

-27.68%

-32.10%

+4.42%

Max Drawdown (10Y)

Largest decline over 10 years

-48.38%

-42.47%

-5.91%

Current Drawdown

Current decline from peak

-9.26%

-21.16%

+11.90%

Average Drawdown

Average peak-to-trough decline

-15.05%

-18.82%

+3.77%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.90%

9.02%

+7.88%

Volatility

CTAS vs. CI - Volatility Comparison

Cintas Corporation (CTAS) has a higher volatility of 11.44% compared to The Cigna Group (CI) at 10.65%. This indicates that CTAS's price experiences larger fluctuations and is considered to be riskier than CI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CTASCIDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.44%

10.65%

+0.79%

Volatility (6M)

Calculated over the trailing 6-month period

19.68%

20.43%

-0.75%

Volatility (1Y)

Calculated over the trailing 1-year period

23.28%

33.83%

-10.55%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.01%

28.73%

-5.72%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.79%

30.70%

-3.91%

Dividends

CTAS vs. CI - Dividend Comparison

CTAS's dividend yield for the trailing twelve months is around 0.88%, less than CI's 2.20% yield.


PositionTTM20252024202320222021202020192018201720162015
CI
The Cigna Group
2.20%2.19%2.03%1.64%1.35%1.74%0.02%0.02%0.02%0.02%0.03%0.03%
CTAS
Cintas Corporation
0.88%0.89%0.80%0.83%0.93%0.77%0.99%0.95%1.22%1.04%1.15%1.15%

Financials

CTAS vs. CI - Financials Comparison

This section allows you to compare key financial metrics between Cintas Corporation and The Cigna Group. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

CTAS vs. CI - Profitability Comparison

The chart below illustrates the profitability comparison between Cintas Corporation and The Cigna Group over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

CTAS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Cintas Corporation reported a gross profit of 1.48B and revenue of 2.91B. Therefore, the gross margin over that period was 51.0%.

CI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, The Cigna Group reported a gross profit of 0.00 and revenue of 71.67B. Therefore, the gross margin over that period was 0.0%.

CTAS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Cintas Corporation reported an operating income of 673.04M and revenue of 2.91B, resulting in an operating margin of 23.2%.

CI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, The Cigna Group reported an operating income of 2.68B and revenue of 71.67B, resulting in an operating margin of 3.7%.

CTAS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Cintas Corporation reported a net income of 510.99M and revenue of 2.91B, resulting in a net margin of 17.6%.

CI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, The Cigna Group reported a net income of 1.66B and revenue of 71.67B, resulting in a net margin of 2.3%.


Frequently Asked Questions


CTAS and CI have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CTAS has higher volatility (11.44%) compared to CI (10.65%). In terms of maximum drawdown, CTAS dropped -65.32% vs CI's -84.34%.

CI currently has the higher Sharpe Ratio (0.21 vs -0.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CTAS and CI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer